SCHEMBL7308464

SCHEMBL7308464

COC(=O)c1cc(Cl)c(NC(C)=O)cc1OC1C=CCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.45
HPGD P15428 7/20 0.42
ALDH1A1 P00352 8/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 4/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
POLB P06746 1/20 0.40
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
DRD2 P14416 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314842 0.78 ABL1 (0.42) LMNAMAPTRAB9ANPC1DRD2
SCHEMBL130152 0.76 HTT (0.72) HTTHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL6213551 0.74 BRD4 (0.44) HPGDALDH1A1SMN1; SMN2LMNARAB9A
SCHEMBL11247336 0.74 HTT (0.45) HTTHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL7410882 0.73 HTT (0.57) HTTHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL7367528 0.71 TDP1 (0.59) HTTHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL31464258 0.71 ALDH1A1 (0.59) HTTHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL7495782 0.70 BRD4 (0.40) HPGDALDH1A1SMN1; SMN2LMNARAB9A
SCHEMBL5384562 0.69 BTK (0.39) HPGDALDH1A1NPSR1KDM4EPOLB
SCHEMBL20099475 0.69 HTT (0.52) HTTHPGDALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246942-A Central nervous system, anti-emetic and gastric prokinetic activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1993-09-21 US disclosed
EP-0494140-A4 DIBENZOFURANCARBOXAMIDES 1992-09-02 EP disclosed
EP-0494140-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1992-07-15 EP disclosed
WO-1991004738-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-04-18 WO disclosed
US-4959485-A 5-HT3 ANTAGONISTS RORER PHARMACEUTICAL CORPORATION (US) 1990-09-25 US disclosed
WO-1989010364-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-11-02 WO disclosed
EP-0339950-A2 Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-11-02 EP disclosed
US-4863921-A Dibenzofurancarboxamides and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-09-05 US disclosed